2021 | Risk factors for neutropenic fever in non-Hodgkin's lymphoma patients with primary granulocyte colony-stimulating factor prophylaxis | 문영철 | Article |
2022 | Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System Lymphoma | 이경은; 문영철 | Article |
2022 | Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma | 문영철 | Article |
2020 | Reduced-Intensity Conditioning with Busulfan and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia | 문영철 | Article |
2022 | Suppressive effect of α-mangostin for cancer stem cells in colorectal cancer via the Notch pathway | 정성애; 문영철; 김성은; 문창모; 김민석; 안영호 | Article |
2022 | Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemia | 성주명; 문영철; 김대영; 박영훈 | Article |
2020 | Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysis | 문영철 | Article |
2020 | Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study) | 문영철 | Article |
2021 | The 2020 revision of the guidelines for the management of myeloproliferative neoplasms | 문영철 | Review |
2021 | Comprehensive DNA repair gene expression analysis and its prognostic significance in acute myeloid leukemia | 이미애; 성주명; 허정원; 문영철; 박영미; 정혜선; 박설희; 김이준 | Article |